Landscapes / Companies
Theralase® Technologies Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 0 checked
Trials
1 active
1 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
TLD-1433not checked |
— |
Phase 2 | Dec 2026Phase 2 trial completes | ||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021